Intrinsic Edge Capital Management LLC Tg Therapeutics, Inc. Transaction History
Intrinsic Edge Capital Management LLC
- $782 Million
- Q3 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 100,000 shares of TGTX stock, worth $2.95 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$2.95 Million% of portfolio
0.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
338Shares Held
88.3MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$336 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$269 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$106 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$94.7 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.29B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...